GlassScriptPhysician profile
Charity G Wilson
NPI 1851568869
$4,033.90
in general payments reported to CMS, 2019-2025
40 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $655 · 2020: $601 · 2021: $523 · 2022: $676 · 2023: $692 · 2024: $504 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,579.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $648.16 | 2019-2024 | Vraylar, Qulipta, Ubrelvy |
| Novo Nordisk INC | $612.09 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astellas Pharma US INC | $595.55 | 2019-2025 | Veozah, Myrbetriq |
| Amgen INC. | $399.55 | 2019-2025 | Evenity |
| Allergan, INC. | $172.58 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $113.39 | 2019-2023 | |
| Corium, LLC | $105.41 | 2023-2024 | Azstarys, Adlarity |
| Astrazeneca Pharmaceuticals LP | $102.79 | 2019-2024 | Flumist Quadrivalent |
| Pfizer INC. | $100.22 | 2024-2025 | |
| Scilex Pharmaceuticals INC. | $88.15 | 2023 | Ztlido |
| Lilly USA, LLC | $82.97 | 2022-2024 | Zepbound, Emgality, Reyvow |
| Bayer Healthcare Pharmaceuticals INC. | $75.29 | 2019-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $68.98 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $68.87 | 2022-2023 | |
| Ironshore Pharmaceuticals INC. | $57.86 | 2019-2024 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charity Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.